C Shih
Impact in
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
- Nutrition and Dietetics top 1%
- Fatty Acid Research and Health
Papers in
-
- Biochemical and Molecular Research 9
- Molecular Biology Techniques and Applications 2
- Oncology 5
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- E. J. Corey (3 shared papers)John R. Cashman (1 shared paper)Robert A. Lewis (2 shared papers)K. Frank Austen (2 shared papers)Richard M. Schultz (6 shared papers)Vinod F. Patel (2 shared papers)Jesse R. Bewley (4 shared papers)L G Mendelsohn (4 shared papers)
- Journals
- Journal of Biological Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Nutrients (1 paper)Toxicology (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
C Shih
21 papers receiving 1.7k citations
C Shih's Hit Papers
Peers
Comparison fields: 5 of 93
- Biochemistry 326
- Nutrition and Dietetics 573
- Pulmonary and Respiratory Medicine 387
- Oncology 321
- Rheumatology 158
Countries citing papers authored by C Shih
This map shows the geographic impact of C Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Shih more than expected).
Fields of papers citing papers by C Shih
This network shows the impact of papers produced by C Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Shih. The network helps show where C Shih may publish in the future.
Co-authors
The 25 scholars most cited alongside C Shih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. | 1997 | 488 |
| 2 | Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Hit paper breakdown → | 1983 | 355 |
| 3 | Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product. Hit paper breakdown → | 1984 | 234 |
| 4 | Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Hit paper breakdown → | 1984 | 222 |
| 5 | Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514. | 1999 | 101 |
| 6 | 1989 | 94 | |
| 7 | Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid. | 1996 | 56 |
| 8 | A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. | 1994 | 54 |
| 9 | 1998 | 50 | |
| 10 | Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts. | 2001 | 47 |
| 11 | Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts. | 2002 | 24 |
| 12 | Metabolism and disposition of the antifolate LY231514 in mice and dogs. | 1997 | 18 |
| 13 | 1992 | 16 | |
| 14 | Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells. | 1999 | 16 |
| 15 | 2001 | 11 | |
| 16 | 1993 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2000 | 5 | |
| 19 | 1998 | 4 | |
| 20 | Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway ; Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway | 2015 | 2 |
About C Shih
C Shih is a scholar working on Molecular Biology, Oncology, Cancer Research, Rheumatology and Physiology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (9 papers), Folate and B Vitamins Research (3 papers), Cancer-related Molecular Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Fatty Acid Research and Health (2 papers), Cancer Treatment and Pharmacology (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Biochemistry (326 citations), Nutrition and Dietetics (573 citations), Pulmonary and Respiratory Medicine (387 citations), Oncology (321 citations) and Rheumatology (158 citations). C Shih has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include E. J. Corey, John R. Cashman, Robert A. Lewis, K. Frank Austen, Richard M. Schultz, Vinod F. Patel, Jesse R. Bewley, L G Mendelsohn, Sherri L. Andis and Jean‐Michel Mencia‐Huerta. Their work appears in journals such as Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Nutrients, Toxicology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.